|
1.
|
|
13 p, 276.7 KB |
Eradication of hepatitis C virus and non-liver-related non-acquired immune deficiency syndrome-related events in human immunodeficiency virus/hepatitis C virus coinfection
/
Berenguer, Juan (Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM)) ;
Rodríguez-Castellano, Elena (Hospital Universitario La Paz (Madrid)) ;
Carrero, Ana (Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM)) ;
Von Wichmann, Miguel A. (Hospital de Donostia (Sant Sebastià, País Basc)) ;
Montero, Marta (Hospital Universitari i Politècnic La Fe (València)) ;
Galindo, María J. (Hospital Clínico Universitario) ;
Mallolas Masferrer, Josep (Hospital Clínic i Provincial de Barcelona) ;
Crespo Casal, Manuel (Complexo Hospitalario Universitario de Vigo) ;
Téllez, María J. (Hospital Clínico San Carlos (Madrid)) ;
Quereda, Carmen (Hospital Universitario Ramón y Cajal (Madrid)) ;
Sanz, José (Hospital Universitario Príncipe de Asturias (Alcalá de Henares, Madrid)) ;
Barros, Carlos (Hospital Universitario de Móstoles (Madrid)) ;
Tural, Cristina (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Santos, Ignacio (Hospital Universitario de la Princesa (Madrid)) ;
Pulido, Federico (Hospital Universitario 12 de Octubre (imas12)) ;
Guardiola Tey, Jose Maria (Institut d'Investigació Biomèdica Sant Pau) ;
Rubio, Rafael (Hospital Universitario 12 de Octubre (imas12)) ;
Ortega, Enrique (Hospital General Universitario) ;
Montes, María L. (Hospital Universitario La Paz (Madrid)) ;
Jusdado, Juan J. (Hospital Universitario Severo Ochoa) ;
Gaspar, Gabriel (Hospital Universitario de Getafe (Madrid)) ;
Esteban, Herminia (Fundación SEIMC-GESIDA) ;
Bellón, José M. (Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM)) ;
González-García, Juan (Hospital Universitario La Paz (Madrid)) ;
Universitat Autònoma de Barcelona
We assessed non-liver-related non-acquired immunodeficiency syndrome (AIDS)-related (NLR-NAR) events and mortality in a cohort of human immunodeficiency virus (HIV)/hepatitis C virus (HCV)-coinfected patients treated with interferon (IFN) and ribavirin (RBV), between 2000 and 2008. [...]
2017 -  10.1002/hep.29071
Hepatology, Vol. 66 Núm. 2 (august 2017) , p. 344-356
|
|
|
2.
|
|
8 p, 249.1 KB |
Human immunodeficiency virus/hepatits C virus coinfection in Spain : Elimination is feasible, but the burden of residual cirrhosis will be significant
/
Berenguer, Juan (Hospital General Universitario Gregorio Marañón) ;
Jarrín, Inma (Instituto de Salud Carlos III) ;
Pérez Latorre, Leire (Hospital General Universitario Gregorio Marañón) ;
Hontañón Antoñana, Víctor (Hospital Universitario La Paz (Madrid)) ;
Vivancos-Gallego, María Jesús (Hospital Universitario Ramón y Cajal (Madrid)) ;
Navarro, Jordi (Hospital Universitari Vall d'Hebron) ;
Téllez, María Jesús (Hospital Clínico San Carlos (Madrid)) ;
Guardiola Tey, Jose Maria (Institut d'Investigació Biomèdica Sant Pau) ;
Iribarren, José Antonio (Hospital de Donostia (Sant Sebastià, País Basc)) ;
Rivero-Juarez, Antonio (Hospital Universitario Reina Sofía (Córdoba, Espanya)) ;
Márquez, Manuel A. (Hospital Universitario Virgen de la Victoria (Màlaga, Andalusia)) ;
Artero, Arturo (Hospital Universitari Doctor Peset (València)) ;
Morano Amado, Luis Enrique (Hospital Álvaro Cunqueiro (Vigo)) ;
de los Santos Gil, Ignacio (Hospital Universitario de la Princesa (Madrid)) ;
Moreno, Javier Marta (Hospital Universitario Miguel Servet (Saragossa)) ;
Fariñas, Mª Carmen (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ;
Galindo, María José (Hospital Clínic Universitari (València)) ;
Hernando, María Asunción (Instituto de Investigación Hospital Universitario 12 de Octubre) ;
Montero, Marta (Hospital la Fe) ;
Cifuentes, Carmen (Hospital Universitari Son Llàtzer (Palma de Mallorca, Balears)) ;
Domingo, Pere (Hospital Universitario Arnau de Vilanova) ;
Sanz, José Miguel (Hospital Universitario Príncipe de Asturias (Alcalá de Henares, Madrid)) ;
Domíngez, Lourdes (Hospital 12 de Octubre (Madrid)) ;
Ferrero, Óscar Luis (Universitario de Basurto) ;
de La Fuente, Belén Pizarro (Hospital Universitario de Cabueñes (Gijón)) ;
Rodríguez, Carmen Herrero (Centro Sanitario Sandoval) ;
Reus, Sergio (Hospital General Universitario de Alicante (Alacant, País Valencià)) ;
Hernàndez-Quero, José (Hospital Clínico San Cecilio) ;
Gaspar Alonso-Vega, Gabriel (Hospital Universitario de Getafe (Madrid)) ;
Pérez-Martínez, Laura (Hospital de la Rioja) ;
García, Coral Fernández (Hospital Universitario Virgen de las Nieves (Granada)) ;
Force, Lluís (Hospital de Mataró. Consorci Sanitari del Maresme) ;
Veloso Esteban, Sergio (Hospital Universitari Joan XXIII de Tarragona) ;
Losa-García, Juan Emilio (Hospital Universitario Fundación Alcorcón) ;
Vilaró, Josep M. (Hospital Universitari de Vic) ;
Bernal, Enrique (Hospital Universitario Reina Sofía (Murcia, Espanya)) ;
Arponen, Sari (Hospital Universitario de Torrejón) ;
Ortí, Amat-Joaquim (Hospital Virgen de la Cinta (Tortosa)) ;
Chocarro, Ángel (Hospital Virgen de la Concha (Zamora)) ;
Teira, Ramón M. (Hospital de Sierrallana (Torrelavega)) ;
Alonso, Gerardo (Hospital Rafael Méndez (Murcia, Espanya)) ;
Silvariño, Rafael (Hospital San Eloy) ;
Vegas, Ana (Hospital Infanta Elena) ;
Geijo, Paloma (Hospital Virgen de La Luz (Cuenca)) ;
Bisbe, Josep (Fundació Hospital Sant Jaume) ;
Esteban, Herminia (Fundación SEIMC-GESIDA) ;
González-García, Juan (Hospital Universitario La Paz (Madrid)) ;
Universitat Autònoma de Barcelona
We assessed the prevalence of antibodies against hepatitis C virus (HCV-Abs) and active HCV infection in patients infected with human immunodeficiency virus (HIV) in Spain in 2016 and compared the results with those of similar studies performed in 2002, 2009, and 2015. [...]
2018 - 10.1093/ofid/ofx258
Open Forum Infectious Diseases, Vol. 5 Núm. 1 (january 2018) , p. ofx258
|
|
|
3.
|
|
20 p, 765.1 KB |
«No todo es sargazo» : aprendizajes en un proyecto de ciencia ciudadana marino-costera
/
Benavides Lahnstein, Ana I. (Natural History Museum (Londres, Regne Unit)) ;
Paredes Chi, Arely A. (Universidad Nacional Autónoma de México) ;
Ríos Vázquez, Ameyalli (Universidad Nacional Autónoma de México) ;
Galindo-De Santiago, María del Carmen (Universidad Nacional Autónoma de México) ;
Khatun, Kaysara (University of Greenwich (Regne Unit)) ;
Vázquez Delfín, Erika (Universidad Nacional Autónoma de México) ;
Robinson, Lucy (Natural History Museum (Londres, Regne Unit)) ;
Brodie, Juliet (Natural History Museum (Londres, Regne Unit)) ;
Wardlaw, Jessica (Natural History Museum (Londres, Regne Unit))
Los efectos de la llegada abundante de macroalgas, como el sargazo, a la península de Yucatán motivó el monitoreo de los arribazones por medio de un proyecto de ciencia ciudadana dirigido a poblaciones afectadas o interesadas. [...]
The effects of the abundant arrival of macroalgae, such as Sargassum, to the Yucatan Peninsula motivated the monitoring of beach-cast seaweeds through a citizen science project aimed at affected and interested populations. [...]
2023 - 10.5565/rev/ensciencias.5940
Enseñanza de las ciencias, Vol. 42 Núm. 1 (2024) , p. 105-123 (Investigaciones Didácticas)
|
|
|
4.
|
|
12 p, 2.3 MB |
Epidemiological trends of HIV/HCV coinfection in Spain, 2015-2019
/
Fanciulli, Chiara (Hospital General Universitario Gregorio Marañón .Instituto de Investigación del Hospital Gregorio Marañón (IiSGM) (Madrid)) ;
Berenguer, Juan ;
Busca, Carmen ;
Vivancos, María J. ;
Téllez, María J. ;
Domínguez, Lourdes ;
Domingo, Pere (Institut d'Investigació Biomèdica Sant Pau) ;
Navarro, Jordi (Hospital Universitari Vall d'Hebrón) ;
Santos, Jesús ;
Iribarren, José A. ;
Morano, Luis ;
Artero, Arturo ;
Moreno, Javier ;
Rivero-Román, Antonio ;
Santos, Ignacio ;
Giner, Livia ;
Armiñanzas, Carlos ;
Montero, Marta ;
Manzardo, Christian (Hospital Santa María. Enfermedades infecciosas) ;
Cifuentes, Carmen ;
García, Coral ;
Galindo, María José ;
Ferrero, Oscar L. ;
Sanz, José ;
de la Fuente, Belén ;
Rodríguez, Carmen ;
Gaspar, Gabriel ;
Pérez, Laura ;
Losa, Juan E. ;
Force, Luis ;
Veloso, Sergio ;
Martínez-Alfaro, Elisa (Complejo Hospitalario Universitario de Albacete. Enfermedades infecciosas) ;
Jarrín, Inma ;
De Miguel, Marta (Fundación SEIMC/GeSIDA) ;
González Garcia, Juan (Hospital Universitario La Paz (Madrid)) ;
Pérez-Latorre, L. ;
Aldámiz-Echevarría, T ;
Díez, C. ;
Tejerina, F. ;
Carretero, S. ;
Gutiérrez, I. ;
Ramírez, M. ;
Padilla, B. ;
López, J.C. ;
Berenguer, J. ;
Núñez, M.J. ;
Arnalich, F. ;
Arribas, Jose ;
Bernardino, J.I. ;
Busca, Carmen ;
Delgado, A. ;
Hontañón Antoñana, Víctor ;
Martín-Carbonero, M.L. ;
Micán, R. ;
Montejano Sanchez, Rocio ;
Montes, M.L. ;
Moreno, V. ;
Pérez-Valero, I. ;
Navarro, C. ;
Valencia, E. ;
González-García, J. ;
Rivero-Juárez, A. ;
Brieva, T. ;
Machuca, I. ;
Camacho, A. ;
Rivero-Román, A. ;
Jarrín, I. ;
Vivancos, M.J. ;
Moreno, S. ;
Moreno, A. ;
Casado, J.L. ;
Pérez-Elías, M.J. ;
Quereda, C. ;
Torrella, A. ;
Planas, B. ;
Navarro, J. ;
Rodrigo, M. ;
Estrada, V. ;
Vergas, J. ;
Téllez, M.J. ;
Muñoz, J. ;
Gutiérrez, M. ;
Mateo, G. ;
Guardiola, J.M. ;
Ibarguren, M. ;
Carmona, M.P. ;
Rodríguez-Arrondo, F. ;
Goenaga, M.A. ;
Azkune, H. ;
Von Wichmann, M.A. ;
Iribarren, J.A. ;
Carmena, J. ;
Artero, Arturo ;
Prado-González, E. ;
Piera-Rojo, G. ;
Ocampo, A. ;
Miralles, C. ;
Crespo Casal, Manuel ;
Morano, L. ;
Ruiz, J. ;
Nuño, E. ;
Palacios, R. ;
Santos, J. ;
Márquez, M. ;
Sanz, J. ;
Santos, I. ;
Moreno, J. ;
Arazo, P. ;
Montero, M. ;
Tasias, M. ;
Cuellar, S. ;
Calabuig, Eva ;
Blanes, M. ;
Fernández, J. ;
López-Aldeguer, J. ;
Salavert, M. ;
Hernando, A. ;
Domínguez, L. ;
Bisbal, Otilia ;
De Lagarde, M. ;
Matarranz, M. ;
Rubio, R. ;
Pulido, F. ;
García, C. ;
Armiñanzas, Carlos ;
Echevarría, S. ;
Gutiérrez-Cuadra, M. ;
Fariñas, C. ;
Giner, L. ;
Reus, S. ;
Merino, E. ;
Boix, Vicente ;
Torrús, D. ;
Portilla, I. ;
Pampliega, M. ;
Díez, M. ;
Egea, I. ;
Portilla, J. ;
Ferrero, O.L. ;
Ibarra, S. ;
López, I. ;
de la Peña, M. ;
Zubero, Z. ;
Baraia, J. ;
Muñoz, J. ;
de Miguel, J. ;
Arranz, A. ;
Casas, E. ;
Sanz, J. ;
Ferrer, A. ;
Galindo, María José ;
García, L. ;
Pérez, L. ;
Oteo, J.A. ;
Velasco, M. ;
Moreno, L. ;
Hervás, R. ;
Losa, J.E. ;
Vinuesa, D. ;
Muñoz, L. ;
Hernández-Quero, J. ;
Veloso, S. ;
Peraire, J. ;
Viladés, C. ;
Vargas, M. ;
Castellano, A. ;
Vidal, F. ;
Silvariño, R. ;
Orti, A.J. ;
Chamarro, E. ;
Escrig, C. ;
Geijo, P. ;
Chocarro, A. ;
Rodríguez, C. ;
Puerta, T. ;
Raposo, M. ;
Vera, M. ;
Del Romero, Jorge ;
Bisbe, J. ;
Cifuentes, C. ;
Teira, R. ;
Vilaró, J. ;
Vegas, A. ;
Cano, A. ;
Alcaráz, A. ;
Muñoz, A. ;
Bernal, Enrique ;
Campoamor, M. ;
Tuya, M.J. ;
de la Fuente, Belén ;
Gimeno, A. ;
Montero-Martínez, Carmen Cecilia Ordoñez ;
Arponen, S. ;
Force, Lluís ;
Barrufet, P. ;
Gaspar, G. ;
Alonso, G. ;
Toledo, C. ;
Peláez, A.I. ;
Lara, G. ;
Fernández, I. ;
Esteban, M.C.
Objectives: We assessed the prevalence of anti-hepatitis C virus (HCV) antibodies and active HCV infection (HCV-RNA-positive) in people living with HIV (PLWH) in Spain in 2019 and compared the results with those of four similar studies performed during 2015-2018. [...]
2022 - 10.1111/hiv.13229
HIV Medicine, Vol. 23 Núm. 7 (august 2022) , p. 705-716
|
|
|
5.
|
|
14 p, 2.9 MB |
HCV eradication with IFN-based therapy does not completely restore gene expression in PBMCs from HIV/HCV-coinfected patients
/
Brochado Kith, Óscar (Instituto de Salud Carlos III) ;
Martínez, Isidoro (Instituto de Salud Carlos III) ;
Berenguer, Juan (Hospital General Universitario Gregorio Marañón) ;
Medrano, Luz María (Instituto de Salud Carlos III) ;
González-García, Juan (Hospital Universitario La Paz (Madrid)) ;
Jiménez-Sousa, María Ángeles (Instituto de Salud Carlos III) ;
Carrero, Ana (Hospital General Universitario Gregorio Marañón) ;
Hontañón Antoñana, Víctor (Hospital Universitario La Paz (Madrid)) ;
Navarro, Jordi (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Guardiola Tey, Jose Maria (Institut d'Investigació Biomèdica Sant Pau) ;
Fernández-Rodríguez, Amanda (Instituto de Salud Carlos III) ;
Resino, Salvador (Instituto de Salud Carlos III) ;
Miralles, P. (GESIDA Study Group) ;
López, J.C. (GESIDA Study Group) ;
Parras, F. (GESIDA Study Group) ;
Padilla, B. (GESIDA Study Group) ;
Aldámiz-Echevarría, T (GESIDA Study Group) ;
Tejerina, F. (GESIDA Study Group) ;
Díez, C. (GESIDA Study Group) ;
Pérez-Latorre, L. (GESIDA Study Group) ;
Fanciulli, C. (GESIDA Study Group) ;
Gutiérrez, I. (GESIDA Study Group) ;
Ramírez, M. (GESIDA Study Group) ;
Carretero, S. (GESIDA Study Group) ;
Bellón, José-María (GESIDA Study Group) ;
Bermejo, Javier (GESIDA Study Group) ;
Arribas, Jose (GESIDA Study Group) ;
Montes, M.L. (GESIDA Study Group) ;
Bernardino, I. (GESIDA Study Group) ;
Pascual, J.F. (GESIDA Study Group) ;
Zamora, Francisco (GESIDA Study Group) ;
Peña, J.M. (GESIDA Study Group) ;
Arnalich, F. (GESIDA Study Group) ;
Díaz, M. (GESIDA Study Group) ;
Domingo, Pere (Institut d'Investigació Biomèdica Sant Pau) ;
Van den Eynde, E. (Hospital Universitari Vall d'Hebron) ;
Pérez, M. (GESIDA Study Group) ;
Ribera, E. (Hospital Universitari Vall d'Hebron) ;
Crespo Casal, Manuel (Hospital Universitari Vall d'Hebron) ;
Casado, José Luis (GESIDA Study Group) ;
Dronda, F. (GESIDA Study Group) ;
Moreno, A. (GESIDA Study Group) ;
Pérez-Elías, M.J. (GESIDA Study Group) ;
Sanfrutos, M.A. (GESIDA Study Group) ;
Moreno, S. (GESIDA Study Group) ;
Quereda, C. (GESIDA Study Group) ;
Arranz, A. (GESIDA Study Group) ;
Casas, E. (GESIDA Study Group) ;
de Miguel, J. (GESIDA Study Group) ;
Schroeder, S. (GESIDA Study Group) ;
Sanz, J. (GESIDA Study Group) ;
Santos, I. (GESIDA Study Group) ;
Bustinduy, M.J. (GESIDA Study Group) ;
Iribarren, J.A. (GESIDA Study Group) ;
Rodríguez-Arrondo, F. (GESIDA Study Group) ;
Von-Wichmann, M.A. (GESIDA Study Group) ;
Vergas, J. (GESIDA Study Group) ;
Téllez, M.J. (GESIDA Study Group) ;
Vinuesa, D. (GESIDA Study Group) ;
Muñoz, L. (GESIDA Study Group) ;
Hernández-Quero, J. (GESIDA Study Group) ;
Ferrer, A. (GESIDA Study Group) ;
Galindo, María José (GESIDA Study Group) ;
Ortiz, L. (GESIDA Study Group) ;
Ortega, E. (GESIDA Study Group) ;
Montero, M. (GESIDA Study Group) ;
Blanes, M. (GESIDA Study Group) ;
Cuellar, S. (GESIDA Study Group) ;
Lacruz, J. (GESIDA Study Group) ;
Salavert, M. (GESIDA Study Group) ;
López-Aldeguer, J. (GESIDA Study Group) ;
Pérez, G. (GESIDA Study Group) ;
Gaspar, G. (GESIDA Study Group) ;
Yllescas, M. (GESIDA Study Group) ;
Crespo, P. (GESIDA Study Group) ;
Aznar, E. (GESIDA Study Group) ;
Esteban, H. (GESIDA Study Group)
Objective: To evaluate the impact of hepatitis C virus (HCV) elimination via interferon (IFN)-based therapy on gene expression profiles related to the immune system in HIV/HCV-coinfected patients. Methods: We conducted a prospective study in 28 HIV/HCV-coinfected patients receiving IFN-based therapy at baseline (HIV/HCV-b) and week 24 after sustained virological response (HIV/HCV-f). [...]
2021 - 10.1186/s12929-021-00718-6
Journal of Biomedical Science, Vol. 28 Núm. 1 (december 2021) , p. 23
|
|
|
6.
|
|
14 p, 846.4 KB |
Real world effectiveness of standard of care triple therapy versus two-drug combinations for treatment of people living with HIV
/
Teira, Ramón (Hospital de Sierrallana) ;
Diaz-Cuervo, Helena (Gilead Sciences. Medical Affairs) ;
Aragão, Filipa (NOVA National School of Public Health. Public Health Research Centre. Lisboa) ;
Marguet, Sophie (Amaris Consulting. Health Economics and Market Access (HEMA)) ;
de la Fuente, Belén (Hospital Universitario de Cabueñes (Gijón)) ;
Muñoz, María José (Hospital de Basurto (Bilbao, Biscaia)) ;
Abdulghani, Nadia (Hospital Arnau de Vilanova (València)) ;
Ribera, Esteban (Hospital Universitari Vall d'Hebron) ;
Domingo, Pere (Institut d'Investigació Biomèdica Sant Pau) ;
Deig, Elisabeth (Hospital General) ;
Peraire, Joaquim (Hospital Universitari Joan XXIII de Tarragona) ;
Roca, Bernardino (Hospital General) ;
Montero, Marta (Hospital Universitari i Politècnic La Fe (València)) ;
Galindo, María José (Hospital Clínico) ;
Romero, Alberto (Hospital Universitario de Puerto Real) ;
Espinosa, Nuria (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
Lozano, Fernando (Hospital Universitario Virgen de Valme (Sevilla, Andalusia)) ;
Merino, María Dolores (Hospital Infanta Elena) ;
Martínez, Elisa (Complejo Hospitalario Universitario de Albacete) ;
Geijo, Paloma (Hospital Virgen de La Luz (Cuenca)) ;
Estrada, Vicente (Hospital Clínico San Carlos (Madrid)) ;
García, Josefina (Hospital Santa Lucía) ;
Sepúlveda, María Antonia (Hospital Virgen de la Salud (Toledo)) ;
Berenguer, Juan (Hospital General Universitario Gregorio Marañón)
BACKGROUND: Since 1996, the standard of care (SOC) therapy for HIV treatment has consisted of a backbone of two nucleoside analogue reverse transcriptase inhibitors (NRTI) paired with a third agent. Use of two-drug combinations (2DC) has been considered for selected patients to avoid toxicities associated with the use of NRTIs. [...]
2021 - 10.1371/journal.pone.0249515
PloS one, Vol. 16 Núm. 4 (2021) , p. e0249515
|
|
|
7.
|
|
19 p, 1.7 MB |
Prevalence, beliefs and impact of drug-drug interactions between antiretroviral therapy and illicit drugs among people living with HIV in Spain
/
Castro-Granell, V. (Hospital Marina Baixa (La Vila Joiosa, Alacant)) ;
Garin, Noe (Institut d'Investigació Biomèdica Sant Pau) ;
Jaén, Ángeles (Fundació Docència i Recerca Mútua Terrassa) ;
Cenoz, Santiago (ViiV Healthcare (Tres Cantos, Madrid)) ;
Galindo, María José (Hospital Clínic Universitari (València)) ;
Fuster-RuizdeApodaca, María José (Sociedad Española Interdisciplinaria del Sida) ;
Universitat Autònoma de Barcelona
Drug use implies important challenges related to HIV management, particularly due to an increased risk of potential interactions between antiretroviral therapy (ART) and illicit drugs (pDDIs). This study analyses the prevalence and severity of pDDIs among people living with HIV (PLHIV). [...]
2021 - 10.1371/journal.pone.0260334
PloS one, Vol. 16 Núm. 11 (november 2021) , p. e0260334
|
|
|
8.
|
|
16 p, 216.2 KB |
El humor en la crónica deportiva : recursos humorísticos de Andrés Montes en las narraciones de la NBA
/
Galindo Merino, Maria del Mar (Universitat d'Alacant) ;
López Fernández, Ángel (Skyhook Magazine & El Remate RSV)
El humor es un fenómeno interdisciplinar a la vez que polifuncional. Como género, ha dado lugar a distintos formatos (chiste, monólogo, parodia, sketch…), pero es, además, un poderós recurso del que se sirven otros géneros no propiamente humorísticos (Ruiz Gurillo 2012, 2019). [...]
Humor is an interdisciplinary and multifunctional phenomenon. As a genre, humor appears under different formats (jokes, monologues, parodies, sketches…), and, at the same time, is a powerful resource for non humorous genres (Ruiz Gurillo 2012, 2019). [...]
2021
Estudios de lingüística del español, Vol. 43 (2021) , p. 35-50 (Articles)
|
|
|
9.
|
|
11 p, 1.6 MB |
Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1
/
Eron, J. J. (University of North Carolina School of Medicine) ;
Orkin, C. (Department of HIV Medicine. Royal Free London NHS Foundation Trust) ;
Cunningham, D. (Pueblo Family Physicians) ;
Pulido, F. (Hospital General Universitario de Alicante (Alacant, País Valencià)) ;
Post, F. (King's College Hospital NHS Foundation Trust) ;
De Wit, Stéphane (Université Libre de Bruxelles) ;
Lathouwers, E. (Janssen Pharmaceutica NV) ;
Hufkens, V. (Janssen Pharmaceutica NV) ;
Jezorwski, J. (Janssen Research & Development) ;
Petrovic, R. (Janssen Pharmaceutica NV) ;
Brown, K. (Janssen Pharmaceutica NV) ;
Van Landuyt, E. (Janssen Pharmaceutica NV) ;
Opsomer, M. (Janssen Pharmaceutica NV) ;
De Wit, Stéphane (Université Libre de Bruxelles) ;
Florence, E. (Institute of Tropical Medicine) ;
Moutschen, M. (Liège University Hospital (Bèlgica)) ;
Van Wijngaerden, E. (University Hospitals Leuven (Bèlgica)) ;
Vandekerckhove, L. (Ghent University Hospital. (Bèlgica)) ;
Vandercam, B. (AIDS Reference center. Cliniques Universitaires Saint-Luc) ;
Brunetta, J. (Maple Leaf Medical Clinic) ;
Conway, B. (Vancouver Infectious Diseases Center) ;
Klein, M. (Division of Infectious Diseases. Faculty of Medicine. McGill University Health Centre) ;
Murphy, D. (Institut national de santé publique du Québec) ;
Rachlis, A. (Sunnybrook Health Sciences Centre) ;
Shafran, S. (Department of Medicine. University of Alberta) ;
Walmsley, S. (University Health Network) ;
Ajana, F. (Infectious Diseases Department. Tourcoing Hospital) ;
Cotte, L. (Hospices Civils de Lyon. Hôpital de la Croix-Rousse) ;
Girardy, P. M. (University Pierre & Marie Curie) ;
Katlama, C. (HIV Clinical Research Unit) ;
Molina, J. M. (Department of Infectious Diseases. St-Louis Hospital APHP. University of Paris Diderot) ;
Poizot-Martin, I. (Clinical Immuno-Hematology Department. Aix-Marseille University. Sainte-Marguerite University Hospital and Inserm U912) ;
Raffi, F. (CHU Hôtel Dieu) ;
Rey, D. (Le Trait d'Union. HIV-Infection Care Center. Hôpitaux Universitaires de Strasbourg) ;
Reynes, J. (University Hospital of Montpellier (França)) ;
Teicher, E. (Infectious Diseases Department. APHP. Hôpital Bicêtre) ;
Yazdanpanah, Y. ;
Gasiorowski, J. (Independent Laboratory for Monitoring Infections among Drug Users at the Department of Infectious Diseases. Liver Disease and Acquired Immune Deficiencies. Wroclaw Medical University) ;
Halota, W. (Department of Infectious Diseases and Hepatology. Nicolaus Copernicus University) ;
Horban, A. (Medical University of Warsaw. Department for Adult's Infectious Diseases) ;
Piekarska, A. (Department of Infectious Diseases and Hepatology. Medical University of Lodz) ;
Witor, A. (Regional Hospital. Out-Patient's Clinic for Immune Deficiency) ;
Arribas, Jose (Instituto de Investigación Sanitaria del Hospital Universitario La Paz) ;
Perez-Valero, I. (Hospital Universitario La Paz (Madrid)) ;
Berenguer, Juan (Hospital General Universitario Gregorio Marañón) ;
Casado, José A. (Hospital Universitario Ramón y Cajal (Madrid)) ;
Gatell, J. M. (Infectious Diseases Department. HCB) ;
Gutiérrez, Félix (Hospital General Universitario de Elche) ;
Galindo, María José (Hospital Clínic Universitari (València)) ;
Gutiérrez Macià, Mª Del Mar (Institut d'Investigació Biomèdica Sant Pau) ;
Iribarren, J. A. (Hospital Universitario de Donostia (Sant Sebastià, País Basc)) ;
Knobel Freud, Hernando (Hospital del Mar (Barcelona, Catalunya)) ;
Negredo Puigmal, Eugènia. (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Pineda, J. A. (Hospital Universitario Virgen de Valme (Sevilla, Andalusia)) ;
Podzamczer, Daniel (Institut d'Investigació Biomèdica de Bellvitge) ;
Sogorb, J. P. (Hospital Universitario 12 de Octubre (Madrid)) ;
Pulido, F. (Hospital General Universitario de Alicante (Alacant, País Valencià)) ;
Ricart, C. (Department of Microbiology. School of Medicine. University of Valencia) ;
Rivero Román, Antonio (Hospital Universitario Reina Sofía (Còrdova, Espanya)) ;
Santos Gil, I. (Hospital Universitario de la Princesa (Madrid)) ;
Blaxhult, A. (Department of Infectious Diseases. Venhälsan. Södersjukhuset) ;
Flamholc, L. (Skåne University Hospital (Suècia)) ;
Gisslèn, M. (Department of Infectious Diseases. University of Gothenburg) ;
Thalme, A. (Karolinska University Hospital and Karolinska Institutet (Suècia)) ;
Fehr, J. (University Hospital Zurich (Suïssa)) ;
Rauch, A. (Bern University Hospital) ;
Stoeckle, M. (University Hospital Basel (Basilea, Suïssa)) ;
Clarke, A. (Claude Nicol Centre. Royal Sussex County Hospital. Brighton and Sussex University Hospitals NHS Trust) ;
Gazzard, B. G. (St. Stephen's Centre. Department of HIV/Genito-Urinary Medicine. Chelsea and Westminster Hospital) ;
Johnson, M. A. (Queen Mary University) ;
Orkin, C. (Department of HIV Medicine. Royal Free London NHS Foundation Trust) ;
Post, F. (King's College Hospital NHS Foundation Trust) ;
Ustianowski, Andrew (Regional Infectious Diseases Unit. North Manchester General Hospital) ;
Waters, L. (University College London Hospital) ;
Bailey, J. (Department of Medicine. Johns Hopkins University School of Medicine) ;
Benson, P. (Be Well Medical) ;
Bhatti, L. (AIDS Healthcare Foundation) ;
Brar, I. (Henry Ford Hospital) ;
Bredeek, U. F. (Metropolis Medical PC) ;
Brinson, C. (Central Texas Clinical Research) ;
Crofoot, G. (The Crofoot Research Center) ;
Cunningham, D. (Pueblo Family Physicians) ;
DeJesus, E. (Pueblo Family Physicians) ;
Dietz, C. (Orlando Immunology Center) ;
Dretler, R. (HIV Medicine. Kansas City Free Health Clinic) ;
Eron, J. (Infectious Disease Specialists of Atlanta) ;
Felizarta, F. (Private Practice) ;
Fichtenbaum, C. (University of Cincinnati College of Medicine) ;
Gallant, J. (Southwest CARE Center) ;
Gathe, J. (Therapeutic Concepts) ;
Hagins, D. (Georgia Department of Public Health. Chatham Care Center) ;
Henn, S. (Whitman-Walker Health) ;
Henry, W. K. (Department of Medicine. University of Minnesota Washington University School of Medicine) ;
Huhn, G. (Ruth M. Rothstein CORE Center) ;
Jain, M. (Department of Internal Medicine. University of Texas Southwestern Medical Center) ;
Lucasti, C. (South Jersey Infectious Disease) ;
Martorell, C. (Infectious Disease and The Research Institute) ;
McDonald, C. (Tarrant County Infectious Disease Associates) ;
Mills, A. (Southern California Men's Medical Group) ;
Morales-Ramirez, J. (Clinical Research Puerto Rico Inc.) ;
Mounzer, K. (Philadelphia FIGHT) ;
Nahass, R. (ID Care) ;
Olivet, H. (Community Research Initiative of New England) ;
Osiyemi, O. (Triple O Research Institute PA) ;
Prelutsky, D. (Department of Internal Medicine. Washington University School of Medicine) ;
Ramgopal, M. (Midway Immunology Center. Fort Pierce) ;
Rashbaum, B. (Capital Medical Associates) ;
Richmond, G. (Broward General Medical Center) ;
Ruane, P. (Ruane Clinical Research Group) ;
Scarsella, A. (Pacific Oaks Medical Group) ;
Scribner, A. (DCOL Center for Clinical Research) ;
Shalit, P. (Peter Shalit MD and Associates) ;
Shamblaw, D. (La Playa Medical Group) ;
Slim, J. (Department of Infectious Diseases. Seton Hall University) ;
Tashima, K. (The Miriam Hospital. Warren Alpert Medical School of Brown University) ;
Voskuhl, G. (AIDS Arms. Inc.) ;
Ward, D. (Dupont Circle Physicians Group) ;
Wilkin, A. (Wake Forest School of Medicine) ;
de Vente, J. (Living Hope Foundation) ;
Universitat Autònoma de Barcelona
Darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) 800/150/200/10 mg was investigated through 96 weeks in EMERALD (NCT02269917). Virologically-suppressed, HIV-1-positive treatment-experienced adults (previous non-darunavir virologic failure [VF] allowed) were randomized (2:1) to D/C/F/TAF or boosted protease inhibitor (PI) plus emtricitabine/tenofovir-disoproxil-fumarate (F/TDF) over 48 weeks. [...]
2019 - 10.1016/j.antiviral.2019.104543
Antiviral Research, Vol. 170 (october 2019) , p. 104543
|
|
|
10.
|
|
18 p, 1.2 MB |
Prevalence and patterns of illicit drug use in people living with HIV in Spain : a cross-sectional study
/
Fuster-RuizdeApodaca, María José (Sociedad Española Interdisciplinaria del Sida-SEISIDA) ;
Castro, Vanessa (Hospital Marina Baixa (La Vila Joiosa, Alacant)) ;
Garin, Noe (Institut d'Investigació Biomèdica Sant Pau) ;
Laguía, Ana (Universidad Nacional de Educación a Distancia (Espanya). Departamento de Psicología Social y de las Organizaciones) ;
Jaén, Ángeles (Mútua de Terrassa) ;
Iniesta, Carlos (Instituto de Salud Carlos III) ;
Cenoz, Santiago (Medical Department. ViiV Healthcare) ;
Galindo, María José (Hospital Clínic Universitari (València)) ;
Universitat Autònoma de Barcelona
This study assessed the prevalence and patterns of drug use among people living with HIV (PLHIV) in Spain. We conducted an observational cross-sectional study including 1401 PLHIV. Data were collected through 33 sites across Spain using an online computer-assisted self-administered interview. [...]
2019 - 10.1371/journal.pone.0211252
PloS one, Vol. 14 Núm. 6 (june 2019) , p. e0211252
|
|
guest ::
email alert
or subscribe to the 
RSS feed.
